Multiple sclerosis trials in Peru

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment

  Where

  Bellavista, La Victoria, Lima, Lima

  Age

  18 years and over

  People

  500 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT06675955 · EU 2023-507633-21-01